February Sees Surge in Healthcare Exec Churn
The healthcare sector saw a significant surge in executive appointments, exits, and layoffs during February. This leadership churn creates both risk and opportunity for imaging service providers, as new executives often reassess vendor relationships and are open to innovative or more efficient solutions.
The broader trend of executive turnover in U.S. public companies is hitting its highest rate in over a decade, with about one in nine CEOs at the 1,500 largest firms being replaced last year. This high rate of change extends into the hospital sector, which saw a 7% increase in CEO exits in 2025 compared to 2024. This leadership churn is occurring as the diagnostic imaging market is projected to grow from $82.42 billion in 2026 to $102.56 billion by 2031. A significant driver of this growth is the strategic shift of imaging services from hospitals to less expensive outpatient settings. Shifting just 10% of hospital-based care to outpatient facilities could yield an estimated $125 billion in annual savings for the U.S. healthcare system. The outpatient imaging sector itself is the fastest-growing end-user segment, with a projected compound annual growth rate of 7.11%. This shift is fueled by site-neutral payment policies and efforts by private payers to direct patients to more cost-effective venues. In response, many hospitals are now pursuing joint ventures with imaging center operators to create freestanding facilities and mitigate volume loss. This market evolution is happening alongside a persistent shortage of radiologists and radiographers, with radiologist attrition rates having jumped 50% since the start of the pandemic. The projected supply of radiologists is not expected to keep pace with the anticipated 17% to 27% growth in imaging utilization through 2055. Simultaneously, the integration of artificial intelligence into radiology is accelerating. By mid-2025, the FDA had approved 873 radiology AI algorithms, making medical imaging the largest target for AI among medical specialties. These AI tools are increasingly being adopted to streamline workflows, prioritize urgent cases, and assist in image interpretation. For imaging providers, new executive teams often conduct thorough reviews of existing vendor contracts, seeking greater efficiency and cost savings. This creates opportunities for providers who can demonstrate value, particularly as hospitals look to standardize products and reduce their number of suppliers. The Centers for Medicare & Medicaid Services (CMS) continues to influence the landscape with reimbursement changes. For 2026, CMS has implemented policies that could reduce payments for some diagnostic imaging services due to new efficiency standards and adjustments to practice expense calculations. For example, the reimbursement for Amyloid PET imaging is set to decrease significantly due to a reassignment of its ambulatory payment classification. Consolidation is a major force in the outpatient market, with private equity firms, hospitals, and large imaging chains actively acquiring smaller centers. This trend, which intensified after the pandemic, is leading to larger and longer imaging IT contracts, making it more challenging for new vendors to enter the market.
